Registrants using Form 222 to order Schedule I or II controlled substances will have a two-year transition period in which to switch to a new single-sheet format, the Drug Enforcement Administration said in a Sept. 30 final rule (84 Fed. Reg. 51368). The triplicate version of the forms may be used within the two-year transition period that begins on the Oct. 30 effective date of th... Read More